Javascript must be enabled to continue!
Effect of Ondansetron and Dexamethasone to Prevent Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
View through CrossRef
Background: Postoperative nausea and vomiting (PONV) remains a significant challenge following laparoscopic cholecystectomy, often prolonging hospital stay and impacting patient recovery. Although ondansetron and dexamethasone are widely used for prophylaxis, direct comparisons of their relative efficacy and safety remain limited in this surgical population. Objective: This study aimed to compare the effectiveness and safety profiles of ondansetron and dexamethasone in preventing PONV among patients undergoing elective laparoscopic cholecystectomy, with additional assessment of postoperative complications and hospital stay. Methods: A cross-sectional, randomized comparative study was conducted among 150 adult patients scheduled for elective laparoscopic cholecystectomy. Patients (n = 75 per group) meeting ASA I/II status and aged 20–70 years were randomly assigned to receive either ondansetron or dexamethasone. Exclusion criteria included comorbidities, drug allergies, and conversion to open surgery. Data were collected using standardized clinical assessment tools, with PONV incidence, complications, and hospital stay as primary outcomes. Ethical approval was obtained in accordance with the Declaration of Helsinki. Data were analyzed using SPSS; chi-square and independent t-tests were employed to determine statistical significance (p < 0.05). Results: Ondansetron significantly reduced PONV incidence (17.3% vs. 44.0%, p < 0.001), complications (17.3% vs. 44.0%, p < 0.001), and shortened hosp5ital stay (1.04 ± 0.20 vs. 2.15 ± 0.62 days, p < 0.001) compared to dexamethasone, which was notably associated with hyperglycemia (26.7%). Conclusion: Ondansetron is superior to dexamethasone for PONV prevention in elective laparoscopic cholecystectomy, providing enhanced safety and facilitating earlier discharge. These findings support ondansetron as the preferred antiemetic in perioperative care, improving clinical outcomes and resource utilization
Title: Effect of Ondansetron and Dexamethasone to Prevent Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
Description:
Background: Postoperative nausea and vomiting (PONV) remains a significant challenge following laparoscopic cholecystectomy, often prolonging hospital stay and impacting patient recovery.
Although ondansetron and dexamethasone are widely used for prophylaxis, direct comparisons of their relative efficacy and safety remain limited in this surgical population.
Objective: This study aimed to compare the effectiveness and safety profiles of ondansetron and dexamethasone in preventing PONV among patients undergoing elective laparoscopic cholecystectomy, with additional assessment of postoperative complications and hospital stay.
Methods: A cross-sectional, randomized comparative study was conducted among 150 adult patients scheduled for elective laparoscopic cholecystectomy.
Patients (n = 75 per group) meeting ASA I/II status and aged 20–70 years were randomly assigned to receive either ondansetron or dexamethasone.
Exclusion criteria included comorbidities, drug allergies, and conversion to open surgery.
Data were collected using standardized clinical assessment tools, with PONV incidence, complications, and hospital stay as primary outcomes.
Ethical approval was obtained in accordance with the Declaration of Helsinki.
Data were analyzed using SPSS; chi-square and independent t-tests were employed to determine statistical significance (p < 0.
05).
Results: Ondansetron significantly reduced PONV incidence (17.
3% vs.
44.
0%, p < 0.
001), complications (17.
3% vs.
44.
0%, p < 0.
001), and shortened hosp5ital stay (1.
04 ± 0.
20 vs.
2.
15 ± 0.
62 days, p < 0.
001) compared to dexamethasone, which was notably associated with hyperglycemia (26.
7%).
Conclusion: Ondansetron is superior to dexamethasone for PONV prevention in elective laparoscopic cholecystectomy, providing enhanced safety and facilitating earlier discharge.
These findings support ondansetron as the preferred antiemetic in perioperative care, improving clinical outcomes and resource utilization.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Comparative antiemetic efficacy of metoclopramide, ondansetron and pyridoxine for the prevention nausea and vomiting in patients undergoing cesarean section under spinal anesthesia
Comparative antiemetic efficacy of metoclopramide, ondansetron and pyridoxine for the prevention nausea and vomiting in patients undergoing cesarean section under spinal anesthesia
Introduction. One of the complications after Cesarean Section is nausea and vomiting, especially during spinal anesthesia. The main causes of nausea and vomiting are complex, and m...
Midazolam versus Ondansetron versus Dexamethasone in Preventing Post-Operative Nausea and Vomiting after Elective Laparoscopic Abdominal Surgeries
Midazolam versus Ondansetron versus Dexamethasone in Preventing Post-Operative Nausea and Vomiting after Elective Laparoscopic Abdominal Surgeries
Abstract
Background
Laparoscopic surgery is associated with a remarkably high risk of post-operative nausea and vomiting. The re...
Incidence and risk factors of postoperative nausea and vomiting in Africa among patient under gone surgery: a systematic review and meta-analysis
Incidence and risk factors of postoperative nausea and vomiting in Africa among patient under gone surgery: a systematic review and meta-analysis
Background:
Patients who experience postoperative nausea and vomiting are not happy with their surgical outcomes. Preventing this problem expedites the patients’ return...
Subhypnotic propofol infusion plus dexamethasone is more effective than dexamethasone alone for the prevention of vomiting in children after tonsillectomy
Subhypnotic propofol infusion plus dexamethasone is more effective than dexamethasone alone for the prevention of vomiting in children after tonsillectomy
SummaryBackground: Postoperative vomiting (POV) is a common complication after tonsillectomy. Dexamethasone is known to decrease postsurgical vomiting. In this study, we compared t...
Effectiveness of dexamethasone and ondansetron in postoperative nausea and vomiting in laparoscopy cholecystectomy.
Effectiveness of dexamethasone and ondansetron in postoperative nausea and vomiting in laparoscopy cholecystectomy.
Objective: To determine the effectiveness of combination of dexamethasone and ondansetron in prevention of postoperative nausea and vomiting in laparoscopic cholecystectomy. Study ...
Comparison of metoclopramide–dexamethasone combination and metoclopramide alone for prophylaxis of postoperative nausea vomiting in laparoscopic cholecystectomy
Comparison of metoclopramide–dexamethasone combination and metoclopramide alone for prophylaxis of postoperative nausea vomiting in laparoscopic cholecystectomy
BACKGROUND & OBJECTIVE: Post operative nausea and vomiting (PONV) is an important concern in laparoscopic surgeries. Aim of this study is to identify the role of metoclopramide...
Comparison of the Prophylactic Effect of Propofol, Dexamethasone and Ondansetron on Post-Operative Nausea and Vomiting in Elective Cesarean Section Under Spinal Anesthesia
Comparison of the Prophylactic Effect of Propofol, Dexamethasone and Ondansetron on Post-Operative Nausea and Vomiting in Elective Cesarean Section Under Spinal Anesthesia
Nausea, and vomiting are common complications in women undergoing cesarean section with spinal anesthesia. This study aimed to compare the propofol, dexamethasone, and ondansetron ...

